Atp13A9 Protein Atpase 13A9 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
ATP13A9 (ATPase 13A9) is a member of the P5-type ATPase family, specifically the P5B subfamily of cation-transporting ATPases. The protein is predicted to be approximately 140 kDa and localizes to the endoplasmic reticulum and lysosomes. Emerging research suggests ATP13A9 may play a role in autophagic flux and lysosomal function, processes that are impaired in [Parkinson's disease](/diseases/parkinsons-disease) and other neurodegenerative disorders.
Structure
ATP13A9 is a member of the P5-type ATPase family, specifically the P5B subfamily of cation-transporting ATPases. While structural details are limited, bioinformatic predictions suggest:
N-terminal Domain: Regulatory region with possible substrate-binding
ATP-binding Domain: Phosphorylation site in the cytoplasmic loop
C-terminal Domain: Regulatory function
Topology
Normal Function
The exact physiological function of ATP13A9 remains under investigation:
Proposed Functions
Relationship to Other ATP13As
ATP13A9 belongs to the ATP13A (PARK9) family:
Role in Disease
Parkinson's Disease
ATP13A9 is a risk factor for PD through GWAS-identified variants:
Risk Variants: Common variants in non-coding regions
Mechanism: Unclear; may affect expression or splicing
Neuronal Relevance: Expressed in dopaminergic [neurons](/entities/neurons)
Potential Mechanisms
Lysosomal Dysfunction: May affect [autophagy](/entities/autophagy)
ER Stress: May affect protein quality control
Calcium Dysregulation: May affect neuronal excitability
Neuroinflammation: May affect immune cell function
Other Conditions
Cancer: Altered expression in some tumors
Metabolic Disease: Possible role in cellular energetics
Therapeutic Targeting
Current Status
Research Directions
Understanding ATP13A9 function in neurons
Developing PD risk models incorporating ATP13A9
Biomarker development for PD risk assessment
Background
The study of Atp13A9 Protein Atpase 13A9 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
ATP13A9 Gene - Gene encoding ATP13A9
ATP13A2 Gene - Related gene (PARK9)
[Parkinson's Disease](/diseases/parkinsons-disease) Primary disease association